Letter to the Editor July 27, 2017

Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss

; ;

Prim Care Companion CNS Disord 2017;19(4):17l02093

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: Interventions in patients with schizophrenia and significant weight loss are not well studied. Here, we discuss a patient with a history of schizophrenia presenting with very limited intake of sustenance and a 40-lb weight loss. During his hospitalization, medications studied for weight gain in patients with an Axis III diagnosis were used, but there was no clinically significant benefit.